Allgens Medical Technology CO., LTD. (SHA:688613)
China flag China · Delayed Price · Currency is CNY
23.20
+0.91 (4.08%)
Mar 10, 2026, 3:00 PM CST

SHA:688613 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
223.51200.43218.43240.28234.15
Other Revenue
-5.68.055.021.91
223.51206.03226.48245.31236.06
Revenue Growth (YoY)
8.48%-9.03%-7.68%3.91%28.46%
Cost of Revenue
-59.439.2440.7935.62
Gross Profit
223.51146.63187.24204.51200.44
Selling, General & Admin
-123.6122.0469.9553.35
Research & Development
-38.7745.557.4633.23
Other Operating Expenses
210.93.572.582.583.09
Operating Expenses
210.9174.08171.22130.690.16
Operating Income
12.6-27.4416.0273.91110.28
Interest Expense
--2.95-3.13-1.87-3.42
Interest & Investment Income
-15.066.185.624.28
Earnings From Equity Investments
----0.53
Currency Exchange Gain (Loss)
--0.1300-0
Other Non Operating Income (Expenses)
0.29-1.13-0.340.05-0.07
EBT Excluding Unusual Items
12.89-16.5918.7377.72111.61
Gain (Loss) on Sale of Investments
-6.3515.110.214.39
Gain (Loss) on Sale of Assets
-0.64-0.59-0.32-
Asset Writedown
-----0.01
Other Unusual Items
-0.6615.858.616.07
Pretax Income
12.89-8.9449.0996.2132.05
Income Tax Expense
-0.268.2-3.874.513.98
Earnings From Continuing Operations
13.15-17.1452.9791.7118.07
Minority Interest in Earnings
-4.481.273.522.71
Net Income
13.15-12.6654.2395.22120.78
Net Income to Common
13.15-12.6654.2395.22120.78
Net Income Growth
---43.04%-21.17%35.80%
Shares Outstanding (Basic)
132141132134120
Shares Outstanding (Diluted)
132141132134120
Shares Change (YoY)
-6.53%6.36%-1.37%12.14%19.66%
EPS (Basic)
0.10-0.090.410.711.01
EPS (Diluted)
0.10-0.090.410.711.01
EPS Growth
---42.25%-29.70%13.48%
Free Cash Flow
--33.0329.7856.6368.54
Free Cash Flow Per Share
--0.230.230.420.57
Dividend Per Share
--0.0600.1070.272
Dividend Growth
---43.92%-60.66%-
Gross Margin
100.00%71.17%82.67%83.37%84.91%
Operating Margin
5.64%-13.32%7.07%30.13%46.72%
Profit Margin
5.88%-6.15%23.95%38.82%51.17%
Free Cash Flow Margin
--16.03%13.15%23.09%29.04%
EBITDA
29.62-10.4330.8188.11121.03
EBITDA Margin
13.25%-5.06%13.61%35.92%51.27%
D&A For EBITDA
17.0217.0214.7914.210.75
EBIT
12.6-27.4416.0273.91110.28
EBIT Margin
5.64%-13.32%7.07%30.13%46.72%
Effective Tax Rate
---4.68%10.59%
Revenue as Reported
-206.03226.48245.31236.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.